Regeneron to purchase 23andMe, commits to safeguarding customer data
The biotechnology company Regeneron Pharmaceuticals is set to acquire the genetic testing company 23andMe for $256 (£192) million...
The biotechnology company Regeneron Pharmaceuticals is set to acquire the genetic testing company 23andMe for $256 (£192) million...
A baby born with a rare genetic liver disease has received the world's first customised experimental treatment that involved directly repairing his DNA to fix a faulty protein...
by Jen Willows
A car bomb has been detonated outside a fertility clinic in California in an 'intentional act of terrorism' according to the FBI...
by Nina O'Toole
A new combination treatment has yielded 100 percent survival for patients with 'aggressive' breast cancers, three years post-surgery...
A prolific sperm donor has been refused parental responsibility and contact with two children he fathered through 'natural insemination'...
The UK Government has postponed proposed updates to 40-year-old surrogacy legislation...
A genetic oral swab test to determine which hormone treatment is best for egg maturation before IVF has been developed...
The International Society for Stem Cell Research hosted a webinar to present the recommendations of its Embryo Models Working Group, which has been drafting updated guidance on research involving SCBEMs...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
Comment
Italy faces backlash over surrogacy and LGBTQ+ families
by Dr Marcin Śmietana
Italy's recent ban on international surrogacy adds to challenges facing LGBTQ+ families in the country, writes Dr Marcin Śmietana...